News & Updates
Filter by Specialty:
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Modified CXI predicts survival in CRC after surgery
The modified cachexia index (mCXI) is effective in predicting the survival outcomes in patients with colorectal cancer (CRC) following radical surgery, reports a study.
Modified CXI predicts survival in CRC after surgery
06 Nov 2024
IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients
Patients with cirrhosis with iron deficiency anemia after variceal bleed (VB) can rely on the efficacy and safety of intravenous (IV) iron replacement, reports a study.
